ID27955A - Senyawa-senyawa antimikroba yang baru - Google Patents

Senyawa-senyawa antimikroba yang baru

Info

Publication number
ID27955A
ID27955A IDW20010052A ID20010052A ID27955A ID 27955 A ID27955 A ID 27955A ID W20010052 A IDW20010052 A ID W20010052A ID 20010052 A ID20010052 A ID 20010052A ID 27955 A ID27955 A ID 27955A
Authority
ID
Indonesia
Prior art keywords
compounds
antimicrobial compounds
new antimicrobial
xvi
xiv
Prior art date
Application number
IDW20010052A
Other languages
English (en)
Indonesian (id)
Inventor
Masatoshi Inukai
Masakatsu Kaneko
Toshio Takatsu
Hitoshi Hotoda
Masatoshi Arai
Shunichi Miyakoshi
Masaaki Kizuka
Yasumasa Ogawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ID27955A publication Critical patent/ID27955A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
IDW20010052A 1998-07-09 1999-07-09 Senyawa-senyawa antimikroba yang baru ID27955A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP26944598 1998-09-24

Publications (1)

Publication Number Publication Date
ID27955A true ID27955A (id) 2001-05-03

Family

ID=26508414

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010052A ID27955A (id) 1998-07-09 1999-07-09 Senyawa-senyawa antimikroba yang baru

Country Status (23)

Country Link
US (2) US6472384B1 (pl)
EP (3) EP1319666B1 (pl)
KR (2) KR100622889B1 (pl)
CN (1) CN1181087C (pl)
AT (2) ATE356825T1 (pl)
AU (1) AU751470B2 (pl)
BR (1) BR9911965A (pl)
CA (1) CA2337225C (pl)
DE (2) DE69927306T2 (pl)
DK (2) DK1319666T3 (pl)
ES (2) ES2284260T3 (pl)
HK (2) HK1053063A1 (pl)
HU (1) HUP0103711A3 (pl)
ID (1) ID27955A (pl)
IL (3) IL140731A0 (pl)
NO (1) NO322083B1 (pl)
NZ (1) NZ509233A (pl)
PL (1) PL200426B1 (pl)
PT (1) PT1095947E (pl)
RU (1) RU2209210C2 (pl)
TR (1) TR200100059T2 (pl)
WO (1) WO2000002892A1 (pl)
ZA (1) ZA200100200B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
WO2002024491A1 (de) 2000-09-25 2002-03-28 Volkswagen Ag Airbagvorrichtung und betriebsverfahren dafür
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
EP1670314A4 (en) * 2003-09-05 2009-02-25 Sequella Inc METHODS AND COMPOSITIONS INCLUDE DIAMINE AS A NEW THERAPEUTIC FOR TUBERCULOSIS
EP1771435A4 (en) * 2004-06-19 2008-02-13 Human Biomolecular Res Inst MODULATORS OF NEUROTRANSMITTERS OF THE CENTRAL NERVOUS SYSTEM
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
PL200426B1 (pl) 2009-01-30
EP1319406A1 (en) 2003-06-18
HK1053127B (en) 2005-12-30
TR200100059T2 (tr) 2001-05-21
HUP0103711A2 (hu) 2002-02-28
CA2337225C (en) 2009-05-26
DE69927306D1 (de) 2005-10-20
NO20010105L (no) 2001-03-08
HUP0103711A3 (en) 2003-11-28
KR100622889B1 (ko) 2006-09-12
CA2337225A1 (en) 2000-01-20
DE69927306T2 (de) 2006-07-06
RU2209210C2 (ru) 2003-07-27
AU751470B2 (en) 2002-08-15
EP1095947B1 (en) 2007-03-14
DE69935513T2 (de) 2007-11-29
PT1095947E (pt) 2007-06-20
KR20010083101A (ko) 2001-08-31
AU4650599A (en) 2000-02-01
US20030069204A1 (en) 2003-04-10
NZ509233A (en) 2003-05-30
HK1053127A1 (en) 2003-10-10
IL187551A0 (en) 2008-03-20
PL345403A1 (en) 2001-12-17
IL140731A (en) 2008-06-05
ATE304548T1 (de) 2005-09-15
NO20010105D0 (no) 2001-01-08
WO2000002892A1 (fr) 2000-01-20
ZA200100200B (en) 2002-06-26
ES2248654T3 (es) 2006-03-16
HK1053063A1 (en) 2003-10-10
ATE356825T1 (de) 2007-04-15
KR20060011919A (ko) 2006-02-03
IL140731A0 (en) 2002-02-10
EP1319666B1 (en) 2005-09-14
KR100729196B1 (ko) 2007-06-19
IL187551A (en) 2009-12-24
DE69935513D1 (de) 2007-04-26
EP1095947A1 (en) 2001-05-02
DK1319666T3 (da) 2005-12-05
US6844173B2 (en) 2005-01-18
US6472384B1 (en) 2002-10-29
DK1095947T3 (da) 2007-07-16
ES2284260T3 (es) 2007-11-01
NO322083B1 (no) 2006-08-14
CN1317008A (zh) 2001-10-10
EP1319666A1 (en) 2003-06-18
EP1095947A4 (en) 2002-01-16
BR9911965A (pt) 2001-05-29
CN1181087C (zh) 2004-12-22

Similar Documents

Publication Publication Date Title
IL187551A0 (en) Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
AP2002002637A0 (en) Novel piperazine
ZA9710796B (en) Oxyiminopregnanecarbolactones.
AU5246596A (en) Compounds as intermediates
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
NZ524857A (en) Piperidine compounds as anti-allergics
GEP20063848B (en) N-substituted hydroxypyrimi-dinone carboxamide inhibitors of hiv integrase
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
ATE203246T1 (de) Dialkyltiacumicine
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
EP0791582A4 (en) DERIVATIVES OF INDOLE-2-CARBOXYLIC ACID ESTERS, AND BACTERICIDES FOR AGRICULTURE AND HORTICULTURE CONTAINING THEM AS ACTIVE INGREDIENTS
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
AU5390900A (en) Potassium channel blocking agents
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques
ATE171451T1 (de) Thiazole mit antiviraler wirkung
IL161896A0 (en) Antibiotics ge 81112 factors a, b, b1 pharmaceutically acceptable salts and compositions, and use thereof
MD1105C2 (ro) N-(5-Nitro-2-furfuriliden)-4-aminobenzensulfamide, care manifestă activitate antimicrobiană
AU6029090A (en) Improvements in or relating to organic compounds